Similarly, multipleex-vivo experiments showed that patients with DM-TB have significantly low complement receptor 3 or CD11b and MARCO levels compared to patients with TB, which translated to low capacity for phagocytosis in macrophages (Pandaet al., 2022). This evidence concerns the gene MARCO and diabetes mellitus.